Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (61-70 of 631) with videos related to

Pageof 64
Sort By:
Experimental Oncology|June 25, 2009
Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformationS P Yenamandra, G Klein, E Kashuba
AIDS Research and Human Retroviruses|January 27, 2021
Human Immunodeficiency Virus Persistence in the Spleen: Opportunities for Pharmacologic InterventionAaron S Devanathan, Angela D M Kashuba
Plos Medicine|February 8, 2008
Antiretroviral therapy for prevention of HIV infection: new clues from an animal modelMyron S Cohen, Angela D M Kashuba
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Fosamprenavir. Vertex Pharmaceuticals/GlaxoSmithKlineAmanda H Corbett, Angela D M Kashuba
Best Practice & Research. Clinical Obstetrics & Gynaecology|February 7, 2012
Formulation, pharmacokinetics and pharmacodynamics of topical microbicidesJessica L Adams, Angela D M Kashuba
Clinical Pharmacology and Therapeutics|October 1, 2010
Pharmacologic opportunities for HIV preventionM R Nicol, A D M Kashuba
Clinical Pharmacokinetics|May 27, 2014
Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV preventionChristine R Trezza, Angela D M Kashuba
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2Muhammad Mushtaq, Larysa Kovalevska, Suhas Darekar, et al.
Clinical Pharmacology and Therapeutics|February 2, 2021
The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral TherapyErin M B Scholz, Angela D M Kashuba
Antimicrobial Agents and Chemotherapy|August 1, 1996
Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidimeA D Kashuba, C H Ballow, A Forrest
Pageof 64

Showing results (61-70 of 631) with videos related to

Sort By:
Pageof 64
Experimental Oncology|June 25, 2009
Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformationS P Yenamandra, G Klein, E Kashuba
AIDS Research and Human Retroviruses|January 27, 2021
Human Immunodeficiency Virus Persistence in the Spleen: Opportunities for Pharmacologic InterventionAaron S Devanathan, Angela D M Kashuba
Plos Medicine|February 8, 2008
Antiretroviral therapy for prevention of HIV infection: new clues from an animal modelMyron S Cohen, Angela D M Kashuba
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Fosamprenavir. Vertex Pharmaceuticals/GlaxoSmithKlineAmanda H Corbett, Angela D M Kashuba
Best Practice & Research. Clinical Obstetrics & Gynaecology|February 7, 2012
Formulation, pharmacokinetics and pharmacodynamics of topical microbicidesJessica L Adams, Angela D M Kashuba
Clinical Pharmacology and Therapeutics|October 1, 2010
Pharmacologic opportunities for HIV preventionM R Nicol, A D M Kashuba
Clinical Pharmacokinetics|May 27, 2014
Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV preventionChristine R Trezza, Angela D M Kashuba
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2Muhammad Mushtaq, Larysa Kovalevska, Suhas Darekar, et al.
Clinical Pharmacology and Therapeutics|February 2, 2021
The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral TherapyErin M B Scholz, Angela D M Kashuba
Antimicrobial Agents and Chemotherapy|August 1, 1996
Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidimeA D Kashuba, C H Ballow, A Forrest
Pageof 64